Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Journal of Hepatocellular Carcinoma|April 29, 2026
Impact of Child Pugh B Stage for the Treatment of Advanced HCCMarie Decraecker, Heloise Bourien, Jean-Frédéric Blanc, et al.
World Journal of Hepatology|January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinomaJean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 2, 2019
Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinomaGaëlle Angenard, Aude Merdrignac, Corentin Louis, et al.
Cardiovascular and Interventional Radiology|February 12, 2022
TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLCBoris Guiu, Etienne Garin, Carole Allimant, et al.
Cardiovascular and Interventional Radiology|August 18, 2022
Trans-arterial Radioembolization Dosimetry in 2022Etienne Garin, Boris Guiu, Julien Edeline, et al.
Liver Cancer|May 29, 2015
Yttrium-90 microsphere radioembolization for hepatocellular carcinomaJulien Edeline, Marine Gilabert, Etienne Garin, et al.
Bulletin Du Cancer|February 15, 2020
[Proton pump inhibitors and cancers: A hazardous association?]Jean-Luc Raoul, Julien Edeline, Marine Gilabert, et al.
World Journal of Gastroenterology|February 18, 2009
Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective studyJulien Edeline, Jean-Luc Raoul, Elodie Vauleon, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2022
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?Gael S Roth, Cindy Neuzillet, Matthieu Sarabi, et al.
Pageof 16